wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34447732-256F706C-A798-4B50-BCD7-6DCF91D327C4
Q34447732-256F706C-A798-4B50-BCD7-6DCF91D327C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34447732-256F706C-A798-4B50-BCD7-6DCF91D327C4
Releasing the brake on the immune system: ipilimumab in melanoma and other tumors
P2860
Q34447732-256F706C-A798-4B50-BCD7-6DCF91D327C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34447732-256F706C-A798-4B50-BCD7-6DCF91D327C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e6d7679ea55e9817e0ef6b31d09e3b992d488e9
P2860
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.